Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.

MLA

Soldovieri, Maria Virginia, et al. “Gabapentin Treatment in a Patient with KCNQ2 Developmental Epileptic Encephalopathy.” Pharmacological Research, vol. 160, Oct. 2020, p. 105200. EBSCOhost, https://doi.org/10.1016/j.phrs.2020.105200.

APA

Soldovieri, M. V., Freri, E., Ambrosino, P., Rivolta, I., Mosca, I., Binda, A., Murano, C., Ragona, F., Canafoglia, L., Vannicola, C., Solazzi, R., Granata, T., Castellotti, B., Messina, G., Gellera, C., Labalme, A., Lesca, G., DiFrancesco, J. C., & Taglialatela, M. (2020). Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy. Pharmacological Research, 160, 105200. https://doi.org/10.1016/j.phrs.2020.105200

Chicago

Soldovieri, Maria Virginia, Elena Freri, Paolo Ambrosino, Ilaria Rivolta, Ilaria Mosca, Anna Binda, Carmen Murano, et al. 2020. “Gabapentin Treatment in a Patient with KCNQ2 Developmental Epileptic Encephalopathy.” Pharmacological Research 160 (October): 105200. doi:10.1016/j.phrs.2020.105200.